Q3 2025
Released Nov 12, 2025, after the close
10-Q filed Nov 12, 2025, 43 days after period end · 0001193125-25-277779
Q3 2025 · 10-Q
Revenue$123.32K$123.32K no prior Q3 2024 on file−8.4% vs Q2 2025
Net Income-$3.05M-$3.05M N/M vs Q3 2024N/M vs Q2 2025
EPS Diluted-$0.06-$0.06 N/M vs Q3 2024N/M vs Q2 2025
Operating Income-$3,380,998N/M
Operating Cash Flowderived-$1,703,197N/M
Free Cash Flowderived-$1,706,096N/M
Margins · derived
Operating margin-2741.7%
Net margin-2473.6%
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2025 | Q3 2024 | Q3 2023 | Q3 2020 |
|---|---|---|---|---|
| Revenue | $123.32K | — | $1.00M | — |
| Net Income | -$3.05M | -$2.85M | -$723.11K | -$3.70M |
| EPS Diluted | -$0.06 | -$0.06 | -$0.01 | -$0.08 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Medicinova Inc · CIK 1226616 · Engraved from SEC EDGAR